1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The market for multi-target MET tyrosine kinase inhibitors (TKIs) is experiencing significant transformation, propelled by innovations in precision oncology and heightened awareness of their ability to address complex tumor biology. As pharmaceutical companies and biotech leaders advance these therapies, stakeholders face evolving clinical, regulatory, and supply chain dynamics influencing adoption and commercialization strategies.
Market Snapshot: Multi-Target MET TKIs in Oncology Therapeutics
Multi-target MET tyrosine kinase inhibitors are reshaping the landscape of oncology therapeutics, establishing themselves as essential agents in precision medicine. These therapies simultaneously modulate MET and other critical signaling pathways involved in tumor progression, resistance, and metastasis. The market reflects increased research activity, accelerated approvals, and expanded use cases driven by advancements in medicinal chemistry and clinical diagnostics.
Scope & Segmentation of the Multi-Target MET TKI Market
This report provides a structured examination of the market, offering actionable insights relevant to senior decision-makers. The scope covers clinical, regional, and commercial dimensions, ensuring comprehensive understanding.
- Indication: Gastric cancer, non-small cell lung cancer, and renal cell carcinoma across first line, second line, and third line and beyond.
- Line of Therapy: Stratification into first line, second line, and advanced or salvage therapy cohorts.
- Distribution Channel: Hospital pharmacy, retail pharmacy, and specialty pharmacy outlets.
- Formulation: Capsule and tablet, each supporting specific clinical and operational benefits.
- Patient Age Group: Adult and elderly populations considering divergent tolerance and comorbidity profiles.
- Regional Coverage: Americas (with detailed segmentation for United States and key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning major national markets and emerging jurisdictions), and Asia-Pacific (including China, India, Japan, Australia, and several Southeast Asian economies).
- Leading Companies Analyzed: Exelixis, Inc., Ipsen S.A., Pfizer Inc.
Technological integration such as next-generation sequencing and predictive biomarkers amplifies the impact of these therapies and supports clinical trial optimization.
Key Takeaways for Senior Decision-Makers
- Multi-target MET TKIs address complex tumor mechanisms, positioning them as strategic assets in precision oncology pipelines.
- The adoption of advanced diagnostic and biomarker strategies enhances patient selection and drives better therapeutic outcomes in carefully stratified populations.
- Emerging partnerships between biopharmaceutical innovators and global manufacturers are accelerating development, streamlining regulatory submissions, and securing market access for novel agents.
- Regional disparities in healthcare delivery and reimbursement policies present targeted opportunities and unique barriers, requiring tailored go-to-market plans.
- Strategic supply chain investments—including near-shoring, digital traceability, and inventory management—are critical for safeguarding continuity amid market volatility.
Tariff Impact on Supply Chains and Pricing Dynamics
The introduction of new 2025 United States tariffs has directly impacted pharmaceutical manufacturing input costs and international distribution of multi-target MET TKIs. Companies are responding by diversifying supplier bases, localizing production when feasible, and pursuing tiered pricing agreements to minimize market disruption. Investments in digital supply chain tools and regulatory advocacy have become vital for overcoming uncertainty and ensuring patient access.
Research Methodology & Data Sources
This analysis leverages a blended methodology, incorporating primary interviews with key stakeholders across clinical, regulatory, and supply chain disciplines, supplemented by exhaustive secondary research including literature reviews, corporate disclosures, and patent analysis. Cross-validation and peer review ensure data accuracy and actionable insights for decision-making.
Why This Report Matters
- Enables executive teams to identify emerging growth opportunities across multiple tumor indications and therapy lines.
- Supports risk mitigation through clear insights into supply chain, regulatory, and pricing challenges affecting multi-target MET TKI commercialization.
- Guides robust strategic planning via in-depth competitor analysis, regional market dynamics, and evolving clinical trial trends.
Conclusion
Multi-target MET TKIs are at the forefront of evolving precision oncology paradigms. Industry leaders equipped with this report can navigate complexity, align strategy, and drive sustained growth in the global oncology therapeutics market.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of next-generation multi-target MET TKIs with improved brain penetration and CNS activity
5.2. Clinical evaluations of combination regimens pairing multi-target MET TKIs with PD-1 and PD-L1 inhibitors to enhance efficacy
5.3. Identification and management of acquired resistance mutations emerging during multi-target MET TKI therapy in NSCLC patients
5.4. Emerging real-world evidence on safety profiles and dose optimization strategies for multi-target MET TKI treatments across diverse populations
5.5. Strategic partnerships between biotech firms and academic institutions to accelerate multi-target MET TKI discovery and clinical translation
5.6. Regulatory approvals and label expansions for multi-target MET TKIs targeting rare MET exon 14 skipping mutations in solid tumors
5.2. Clinical evaluations of combination regimens pairing multi-target MET TKIs with PD-1 and PD-L1 inhibitors to enhance efficacy
5.3. Identification and management of acquired resistance mutations emerging during multi-target MET TKI therapy in NSCLC patients
5.4. Emerging real-world evidence on safety profiles and dose optimization strategies for multi-target MET TKI treatments across diverse populations
5.5. Strategic partnerships between biotech firms and academic institutions to accelerate multi-target MET TKI discovery and clinical translation
5.6. Regulatory approvals and label expansions for multi-target MET TKIs targeting rare MET exon 14 skipping mutations in solid tumors
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Multi-target MET TKIs Market, by Indication
8.1. Introduction
8.2. Gastric Cancer
8.2.1. First Line
8.2.2. Second Line
8.2.3. Third Line And Beyond
8.3. Non Small Cell Lung Cancer
8.3.1. First Line
8.3.2. Second Line
8.3.3. Third Line And Beyond
8.4. Renal Cell Carcinoma
8.4.1. First Line
8.4.2. Second Line
8.4.3. Third Line And Beyond
8.2. Gastric Cancer
8.2.1. First Line
8.2.2. Second Line
8.2.3. Third Line And Beyond
8.3. Non Small Cell Lung Cancer
8.3.1. First Line
8.3.2. Second Line
8.3.3. Third Line And Beyond
8.4. Renal Cell Carcinoma
8.4.1. First Line
8.4.2. Second Line
8.4.3. Third Line And Beyond
9. Multi-target MET TKIs Market, by Line Of Therapy
9.1. Introduction
9.2. First Line
9.3. Second Line
9.4. Third Line And Beyond
9.2. First Line
9.3. Second Line
9.4. Third Line And Beyond
10. Multi-target MET TKIs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Retail Pharmacy
10.4. Specialty Pharmacy
10.2. Hospital Pharmacy
10.3. Retail Pharmacy
10.4. Specialty Pharmacy
11. Multi-target MET TKIs Market, by Formulation
11.1. Introduction
11.2. Capsule
11.3. Tablet
11.2. Capsule
11.3. Tablet
12. Multi-target MET TKIs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Elderly
12.2. Adult
12.3. Elderly
13. Americas Multi-target MET TKIs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Multi-target MET TKIs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Multi-target MET TKIs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Exelixis, Inc.
16.3.2. Ipsen S.A.
16.3.3. Pfizer Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Exelixis, Inc.
16.3.2. Ipsen S.A.
16.3.3. Pfizer Inc.
List of Figures
FIGURE 1. MULTI-TARGET MET TKIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MULTI-TARGET MET TKIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MULTI-TARGET MET TKIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MULTI-TARGET MET TKIS MARKET: RESEARCHAI
FIGURE 26. MULTI-TARGET MET TKIS MARKET: RESEARCHSTATISTICS
FIGURE 27. MULTI-TARGET MET TKIS MARKET: RESEARCHCONTACTS
FIGURE 28. MULTI-TARGET MET TKIS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MULTI-TARGET MET TKIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MULTI-TARGET MET TKIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MULTI-TARGET MET TKIS MARKET: RESEARCHAI
FIGURE 26. MULTI-TARGET MET TKIS MARKET: RESEARCHSTATISTICS
FIGURE 27. MULTI-TARGET MET TKIS MARKET: RESEARCHCONTACTS
FIGURE 28. MULTI-TARGET MET TKIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MULTI-TARGET MET TKIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 108. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 109. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 110. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 111. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 112. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 113. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 114. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 115. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 120. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 121. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 128. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 129. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 130. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 131. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 206. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 210. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 211. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 212. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 213. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 222. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 226. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 227. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 228. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 229. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 254. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 255. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 256. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 257. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 258. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 259. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 260. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 261. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 266. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 267. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 270. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 272. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 274. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 275. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 276. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 277. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MIL
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MULTI-TARGET MET TKIS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MULTI-TARGET MET TKIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 108. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 109. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 110. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 111. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 112. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 113. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 114. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 115. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 120. CANADA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 121. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 128. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 129. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 130. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 131. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. MEXICO MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 206. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 210. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 211. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 212. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 213. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. GERMANY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 222. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 226. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 227. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 228. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 229. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. FRANCE MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 254. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 255. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 256. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 257. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 258. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 259. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 260. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 261. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 266. ITALY MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 267. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 270. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 272. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 274. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 275. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 276. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 277. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. SPAIN MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA MULTI-TARGET MET TKIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY GASTRIC CANCER, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MULTI-TARGET MET TKIS MARKET SIZE, BY RENAL CELL CARCINOMA, 2018-2024 (USD MIL
Samples
LOADING...
Companies Mentioned
The companies profiled in this Multi-target MET TKIs Market report include:- Exelixis, Inc.
- Ipsen S.A.
- Pfizer Inc.
